Why is the global CNS pharmaceutical market so under-penetrated?

Drug Discov Today. 2002 Jan 1;7(1):5-7. doi: 10.1016/s1359-6446(01)02082-7.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Blood-Brain Barrier
  • Central Nervous System Agents* / therapeutic use
  • Central Nervous System Diseases / drug therapy
  • Cost Control
  • Drug Industry / economics
  • Drug Industry / trends*
  • Health Care Sector / statistics & numerical data*

Substances

  • Central Nervous System Agents